IFLScience on MSN
CAR-T therapy is revolutionizing cancer treatment. Next on the list: autoimmune disease
A woman who had been sick for many years with three autoimmune conditions has experienced a remarkable recovery after being ...
In a bar, a poet meets the man behind the drug that saved his life — discovering how science, faith and chance created a future thought impossible.
Your veterinarian may recommend that your pet has bloodwork for a large variety of reasons. Maybe you have a dog who started vomiting yesterday and still isn’t feeling well, or, ...
Robot adoption is advancing rapidly, driven by declining costs, rising demand, and the integration of artificial intelligence ...
A new blood test combined with a standardized questionnaire and artificial intelligence may transform the way leprosy is ...
Researchers have developed a new tool to help clinicians tailor personalized treatment plans for patients with a rare blood ...
4don MSNOpinion
AI can design and run thousands of lab experiments without human hands. Humanity isn’t ready for the new risks this brings to biology
Artificial intelligence is rapidly learning to autonomously design and run biological experiments, but the systems intended ...
Personalized approaches have dramatically improved outcomes for many patients with non-Hodgkin B-cell lymphomas—blood cancers ...
New cfDNA test enables multicancer detection with high accuracy, offering a cost effective approach for early diagnosis and screening.
Typically, their AI product is an explanatory report, written in accessible language, that provides a personalized plan with next steps, like dietary changes, lifestyle modifications, and consultation ...
Beckman Coulter Diagnostics, a Danaher company and global leader in clinical diagnostics, today announced it has received CE 2797 mark under IVDR for the Access MeMed BV assay, enabling broad ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results